You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,867,863


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,867,863 protect, and when does it expire?

Patent 9,867,863 protects GIAPREZA and is included in one NDA.

Summary for Patent: 9,867,863
Title:Method of treating low blood pressure
Abstract: A method for treating a patient suffering from one of septic shock, acute kidney injury, severe hypotension, cardiac arrest, and refractory hypotension, but not from myocardial infarction, is provided. The method includes administering a therapeutically effective dose of Angiotensin II, or Ang II, to the patient.
Inventor(s): Chawla; Lakhmir (McLean, VA)
Assignee: The George Washington University a Congressionally Chartered Not-for-Profit Corporation (Washington, DC)
Application Number:15/380,574
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,867,863

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 9,867,863, exploring its claims, the patent landscape, and the implications of its scope.

Patent Overview

United States Patent 9,867,863 is part of a broader patent family, often related to specific technological or pharmaceutical innovations. To analyze this patent, we need to consider the context in which it was granted.

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of the invention. The claims of U.S. Patent 9,867,863 would typically be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Types

  • Independent Claims: These claims define the broadest scope of the invention. For example, if the patent is related to a medical therapy, an independent claim might describe the method of administering the therapy.
  • Dependent Claims: These claims narrow down the invention by adding specific limitations to the independent claims. For instance, a dependent claim might specify the dosage or the particular patient population.

Patent Scope

Patent Scope Measurements

The scope of a patent can be measured using various metrics, such as the number of claims, the breadth of the claims, and the dependency relationships between claims. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including scope measurements. This dataset can help in understanding the scope of U.S. Patent 9,867,863 by analyzing the claim-level statistics and document-level statistics[3].

Prior Art and Novelty

The scope of the patent is also defined by its novelty and non-obviousness over prior art. The patent must introduce a new and useful process, machine, manufacture, or composition of matter, or an improvement thereof, as outlined in 35 U.S.C. ยง 101[2].

Patent Landscape

Related Patents and Patent Families

To understand the broader patent landscape, it is essential to identify related patents and patent families. Tools like the USPTO's Global Dossier and the Common Citation Document (CCD) can help in visualizing the patent family and identifying related applications filed at participating IP Offices[1].

International Patent Offices

The patent landscape extends beyond U.S. borders. Searching international patent offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) can reveal whether similar patents have been granted or applied for in other countries[1].

Legal Implications

Patent Infringement and Validity

The validity and enforceability of the patent claims are critical. As seen in cases like AI Visualize, Inc. v. Nuance Communications, Inc., claims must not be directed to patent-ineligible subject matter and must provide an inventive step that transforms an abstract idea into a patent-eligible invention[2].

Defensive Strategies

Companies often defend their intellectual property rights vigorously. For example, La Jolla Pharmaceutical Company defended its patent rights for GIAPREZA under the Hatch-Waxman Act, which allows for a stay on FDA approval of generic versions if a patent infringement lawsuit is filed within a specified timeframe[4].

Search and Analysis Tools

USPTO Resources

The USPTO provides several tools for searching and analyzing patents, including the Patent Public Search tool, the Public Search Facility, and Patent and Trademark Resource Centers (PTRCs). These resources can help in conducting a thorough search of prior art and understanding the patent landscape[1].

Global Dossier and CCD

The Global Dossier and Common Citation Document (CCD) are particularly useful for analyzing the international aspects of a patent. These tools provide access to file histories, patent family information, and citation data from participating IP Offices[1].

Case Studies and Examples

AI Visualize, Inc. v. Nuance Communications, Inc.

This case highlights the importance of ensuring that patent claims are not directed to abstract ideas without an inventive step. The court's decision to dismiss the case due to the claims being patent-ineligible subject matter underscores the need for careful claim drafting[2].

Key Takeaways

  • Claims Analysis: Understanding the structure and types of claims is crucial for defining the scope of the patent.
  • Patent Scope: Measuring the scope using metrics from the USPTO's Patent Claims Research Dataset helps in understanding the breadth and novelty of the invention.
  • Patent Landscape: Identifying related patents and international filings is essential for a comprehensive analysis.
  • Legal Implications: Ensuring claims are valid and enforceable, and understanding defensive strategies, is vital for protecting intellectual property.
  • Search and Analysis Tools: Utilizing USPTO resources, Global Dossier, and CCD can facilitate a thorough analysis.

FAQs

Q: How do I search for existing patents related to my invention? A: You can use the USPTO's Patent Public Search tool, visit the Public Search Facility, or contact your nearest Patent and Trademark Resource Center (PTRC) for assistance[1].

Q: What is the significance of the Global Dossier in patent searching? A: The Global Dossier provides access to file histories of related applications from participating IP Offices, allowing users to see the patent family and related data in a single portal[1].

Q: How do I determine if my patent claims are valid and enforceable? A: Ensure that your claims are not directed to patent-ineligible subject matter and provide an inventive step. Consult legal experts and use tools like the USPTO's resources to analyze prior art and claim scope[2].

Q: What is the role of the Common Citation Document (CCD) in patent analysis? A: The CCD consolidates prior art cited by all participating offices for the family members of a patent application, enabling users to visualize search results on a single page[1].

Q: How can I protect my intellectual property rights if someone files a generic version of my patented product? A: You can file a patent infringement lawsuit within the specified timeframe under laws like the Hatch-Waxman Act to prevent FDA approval of the generic version until the legal dispute is resolved[4].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC.: https://cafc.uscourts.gov/opinions-orders/22-2109.OPINION.4-4-2024_2296276.pdf
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. LA JOLLA PHARMACEUTICAL CO - Other Events, Financial Statements and Exhibits: https://www.marketscreener.com/quote/stock/LA-JOLLA-PHARMACEUTICAL-C-23894309/news/LA-JOLLA-PHARMACEUTICAL-CO-Other-Events-Financial-Statements-and-Exhibits-form-8-K-39490691/

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,867,863

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-003 Dec 23, 2021 RX Yes Yes 9,867,863 ⤷  Subscribe TREATING REFRACTORY HYPOTENSION WITH ABOUT 5 NG/KG/MIN TO ABOUT 20 NG/KG/MIN ANGIOTENSIN II IN A PATIENT RECEIVING VASOPRESSOR ⤷  Subscribe
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-001 Dec 21, 2017 RX Yes Yes 9,867,863 ⤷  Subscribe TREATING REFRACTORY HYPOTENSION WITH ABOUT 5 NG/KG/MIN TO ABOUT 20 NG/KG/MIN ANGIOTENSIN II IN A PATIENT RECEIVING VASOPRESSOR ⤷  Subscribe
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-002 Dec 21, 2017 DISCN Yes No 9,867,863 ⤷  Subscribe TREATING REFRACTORY HYPOTENSION WITH ABOUT 5 NG/KG/MIN TO ABOUT 20 NG/KG/MIN ANGIOTENSIN II IN A PATIENT RECEIVING VASOPRESSOR ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.